QUIDELORTHO CORPORATION

(QDEL)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
92.20 USD   -5.11%
08/04QUIDELORTHO : Q2 Earnings Snapshot
AQ
08/04QuidelOrtho Q2 Earnings More Than Double, Revenue Rises
MT
08/04QUIDELORTHO : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/01/2022 08/02/2022 08/03/2022 08/04/2022 08/05/2022 Date
101.91(c) 100.83(c) 101.575(c) 97.17(c) 92.2(c) Last
771 216 611 293 640 050 940 274 1 642 193 Volume
-0.13% -1.06% +0.74% -4.34% -5.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 3 337 M - -
Net income 2022 504 M - -
Net Debt 2022 2 294 M - -
P/E ratio 2022 10,5x
Yield 2022 -
Sales 2023 2 849 M - -
Net income 2023 147 M - -
Net Debt 2023 1 797 M - -
P/E ratio 2023 58,4x
Yield 2023 -
Capitalization 6 173 M 6 173 M -
EV / Sales 2022 2,54x
EV / Sales 2023 2,80x
Nbr of Employees 1 600
Free-Float 92,3%
More Financials
Company
QuidelOrtho Corporation is a vitro diagnostics company. The Company is engaged in the development and manufacturing of advanced technologies in diagnostic testing. Its product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and a range of clinical and at-home products to detect COVID-19. The Company’s capabilities include immunoassay... 
More about the company
Ratings of QuidelOrtho Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about QUIDELORTHO CORPORATION
08/04QUIDELORTHO : Q2 Earnings Snapshot
AQ
08/04QuidelOrtho Q2 Earnings More Than Double, Revenue Rises
MT
08/04QUIDELORTHO : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/04TRANSCRIPT : QuidelOrtho Corporation, Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04QuidelOrtho Reports Second Quarter 2022 Financial Results
BU
08/04Earnings Flash (QDEL) QUIDELORTHO CORPORATION Posts Q2 Revenue $613.4M
MT
08/04QuidelOrtho Corporation Reports Earnings Results for the Second Quarter and Six Months ..
CI
07/26Ortho ranks no. 1 in customer satisfaction for 5 years in a row
PR
07/20UBS Initiates Coverage on Quidel With Sell Rating, $86 Price Target
MT
07/18QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022
GL
07/18QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022
AQ
06/24QUIDELORTHO CORPORATION(NASDAQGS : QDEL) dropped from Russell 1000 Growth Index
CI
06/24QUIDELORTHO CORPORATION(NASDAQGS : QDEL) dropped from Russell Midcap Growth Index
CI
06/24QUIDELORTHO CORPORATION(NASDAQGS : QDEL) dropped from Russell 3000E Growth Index
CI
06/24QUIDELORTHO CORPORATION(NASDAQGS : QDEL) dropped from Russell 3000 Growth Index
CI
More news
News in other languages on QUIDELORTHO CORPORATION
08/04Les bénéfices de QuidelOrtho au deuxième trimestre ont plus que doublé et les revenus o..
08/04Earnings Flash (QDEL) QUIDELORTHO CORPORATION affiche un chiffre d'affaires de 613,4 mi..
08/04QuidelOrtho Corporation annonce ses résultats pour le deuxième trimestre et le semestre..
05/27QUIDEL CORPORATION (NASDAQGS : QDEL) a finalisé l'acquisition d'Ortho Clinical Diagnostics..
05/26Quidel et Ortho Clinical s'attendent à ce que la transaction en cours soit conclue vend..
More news
Analyst Recommendations on QUIDELORTHO CORPORATION
More recommendations
Chart QUIDELORTHO CORPORATION
Duration : Period :
QuidelOrtho Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUIDELORTHO CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 92,20 $
Average target price 135,25 $
Spread / Average Target 46,7%
EPS Revisions
Managers and Directors
Douglas C. Bryant Chairman & Chief Executive Officer
Robert Joseph Bujarski President & Chief Operating Officer
Joseph Michael Busky Chief Financial Officer
Werner Kroll Senior Vice President-Research & Development
Kenneth F. Buechler Director
Sector and Competitors